内科住院营养不良风险患者的个体化营养支持:一项随机临床试验
EFFORT试验为务实、研究者发起的开放标签多中心研究,纳入8家瑞士医院NRS 2002评分≥3分且预计住院超过4天的内科患者2088例,随机分入方案引导的个体化营养支持组或标准医院饮食组。30天时干预组不良临床结局发生率23%低于对照组27%(校正OR 0.79,95%CI 0.64-0.97,p=0.023),干预组死亡7%低于对照组10%(校正OR 0.65,95%CI 0.47-0.91,p=0.011),两组营养支持副作用比例无差异。
要点
- NRS 2002评分≥3分的内科住院患者,个体化营养支持较标准饮食降低30天不良结局风险(校正OR 0.79)。
- 干预组30天死亡7%,低于对照组10%(校正OR 0.65,95%CI 0.47-0.91,p=0.011)。
- 两组营养支持副作用比例无差异(16% vs 14%,校正OR 1.16,95%CI 0.90-1.51,p=0.26)。
核心结论
- 在内科住院营养不良风险患者中,住院期间使用个体化营养支持较标准医院饮食改善了重要临床结局,包括生存。
- 这些发现强烈支持以下理念:所有内科住院患者入院时不论其疾病状况均系统筛查营养风险,随后对存在风险者进行营养评估并引入个体化营养支持。
研究设计与样本
- EFFORT试验为务实、研究者发起的开放标签多中心研究,在8家瑞士医院招募NRS 2002评分≥3分且预计住院超过4天的内科患者。
- 采用交互式网络应答系统按可变区组大小随机化(1:1),并按研究地点和营养不良严重程度分层。
- 共筛查5015例患者,2014年4月1日至2018年2月28日期间招募并监测2088例,干预组1050例、对照组1038例。
- 试验期间60例撤回知情同意(干预组35例、对照组25例),主要终点在完成试验的所有随机化患者中测量。
- 干预组由专科营养师制定个体化营养支持目标,营养支持不晚于入院后48小时内启动;对照组不接受饮食咨询。
主要发现
- 住院期间干预组1015例患者中,800例(79%)达到热量目标,770例(76%)达到蛋白质目标。
- 30天时干预组232例(23%)发生不良临床结局,对照组1013例中272例(27%)发生(校正OR 0.79,95%CI 0.64-0.97,p=0.023)。
- 30天时干预组73例(7%)死亡,对照组100例(10%)死亡(校正OR 0.65,95%CI 0.47-0.91,p=0.011)。
- 营养支持副作用发生率干预组162例(16%)与对照组145例(14%)无差异(校正OR 1.16,95%CI 0.90-1.51,p=0.26)。
关键数值与推荐
- 营养风险筛查采用NRS 2002评分≥3分作为纳入标准。
- 复合主要终点包括30天全因死亡、入住重症监护室、非计划再入院、主要并发症和功能状态下降。
临床怎么用
- 作者认为这些发现强烈支持对所有内科住院患者入院时不论疾病状况均系统筛查营养风险,随后对存在风险者进行营养评估并引入个体化营养支持。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines recommend the use of nutritional support during hospital stays for medical patients (patients not critically ill and not undergoing surgical procedures) at risk of malnutrition. However, the supporting evidence for this recommendation is insufficient, and there is growing concern about the possible negative effects of nutritional therapy during acute illness on recovery and clinical outcomes. Our aim was thus to test the hypothesis that protocol-guided individualised nutritional support to reach protein and caloric goals reduces the risk of adverse clinical outcomes in medical inpatients at nutritional risk. METHODS: The Effect of early nutritional support on Frailty, Functional Outcomes, and Recovery of malnourished medical inpatients Trial (EFFORT) is a pragmatic, investigator-initiated, open-label, multicentre study. We recruited medical patients at nutritional risk (nutritional risk screening 2002 [NRS 2002] score ≥3 points) and with an expected length of hospital stay of more than 4 days from eight Swiss hospitals. These participants were randomly assigned (1:1) to receive either protocol-guided individualised nutritional support to reach protein and caloric goals (intervention group) or standard hospital food (control group). Randomisation was done with variable block sizes and stratification according to study site and severity of malnutrition using an interactive web-response system. In the intervention group, individualised nutritional support goals were defined by specialist dietitians and nutritional support was initiated no later than 48 h after admission. Patients in the control group received no dietary consultation. The composite primary endpoint was any adverse clinical outcome defined as all-cause mortality, admission to intensive care, non-elective hospital readmission, major complications, and decline in functional status at 30 days, and it was measured in all randomised patients who completed the trial. This trial is registered with ClinicalTrials.gov, number NCT02517476. FINDINGS: 5015 patients were screened, and 2088 were recruited and monitored between April 1, 2014, and Feb 28, 2018. 1050 patients were assigned to the intervention group and 1038 to the control group. 60 patients withdrew consent during the course of the trial (35 in the intervention group and 25 in the control group). During the hospital stay, caloric goals were reached in 800 (79%) and protein goals in 770 (76%) of 1015 patients in the intervention group. By 30 days, 232 (23%) patients in the intervention group experienced an adverse clinical outcome, compared with 272 (27%) of 1013 patients in the control group (adjusted odds ratio [OR] 0·79 [95% CI 0·64-0·97], p=0·023). By day 30, 73 [7%] patients had died in the intervention group compared with 100 [10%] patients in the control group (adjusted OR 0·65 [0·47-0·91], p=0·011). There was no difference in the proportion of patients who experienced side-effects from nutritional support between the intervention and the control group (162 [16%] vs 145 [14%], adjusted OR 1·16 [0·90-1·51], p=0·26). INTERPRETATION: In medical inpatients at nutritional risk, the use of individualised nutritional support during the hospital stay improved important clinical outcomes, including survival, compared with standard hospital food. These findings strongly support the concept of systematically screening medical inpatients on hospital admission regarding nutritional risk, independent of their medical condition, followed by a nutritional assessment and introduction of individualised nutritional support in patients at risk. FUNDING: The Swiss National Science Foundation and the Research Council of the Kantonsspital Aarau, Switzerland.
引用
- Schuetz P, Fehr R, Baechli V, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019. PMID: 31030981. doi:10.1016/S0140-6736(18)32776-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。